Outcomes of re-excision after unplanned excisions of soft-tissue sarcomas

Mark W. Manoso, Deborah Frassica, E Gene Deune, Frank J. Frassica

Research output: Contribution to journalArticle

Abstract

Background and Objectives: Unplanned excisions of soft-tissue sarcomas of the extremities occur commonly. Our goal was to evaluate the presence of residual disease, the treatment outcomes as they relate to local and distant recurrence and 5-year survival, and the limb functional outcomes in patients with unplanned sarcoma excision who were treated with re-excision and adjuvant therapy. Methods: Between 1993 and 1999, 42 patients presented to our institution after unplanned excision of soft-tissue sarcomas. Of those 42 patients, 38 without gross residual disease or metastatic lesions formed the basis of this review. All 38 patients underwent revision wide excision; most (31) also received adjuvant therapy (radiation and/or chemotherapy). Clinical data were obtained from analysis of patient records and radiographic studies. Univariate analysis was performed with logistical regression, and multivariate analysis was performed with Cox modeling. Results: The overall 5-year survival rate was 91.3% and the disease-free 5-year survival rate was 82.2%. Univariate analysis showed that stage-III disease (American Joint Committee on Cancer classification of soft-tissue sarcomas), lesions below the fascia, a histologic high-grade, and the development of organ metastasis were statistically significant factors for mortality. Stage-III disease also was significant for mortality on multivariate analysis. Only stage-III disease was significant for the development of local recurrence. Eighty-four percent of the patients had good to excellent functional outcomes. Conclusions: Re-excision with adjuvant therapy proved to be a safe and effective method for treating the disease and preserving limb function.

Original languageEnglish (US)
Pages (from-to)153-158
Number of pages6
JournalJournal of Surgical Oncology
Volume91
Issue number3
DOIs
StatePublished - Sep 1 2005

Fingerprint

Sarcoma
Extremities
Multivariate Analysis
Survival Rate
Recurrence
Mortality
Joint Diseases
Fascia
Radiotherapy
Regression Analysis
Neoplasm Metastasis
Drug Therapy
Survival
Therapeutics
Neoplasms

Keywords

  • Predictive factors
  • Recurrence
  • Wide excision

ASJC Scopus subject areas

  • Surgery
  • Oncology

Cite this

Outcomes of re-excision after unplanned excisions of soft-tissue sarcomas. / Manoso, Mark W.; Frassica, Deborah; Deune, E Gene; Frassica, Frank J.

In: Journal of Surgical Oncology, Vol. 91, No. 3, 01.09.2005, p. 153-158.

Research output: Contribution to journalArticle

Manoso, Mark W. ; Frassica, Deborah ; Deune, E Gene ; Frassica, Frank J. / Outcomes of re-excision after unplanned excisions of soft-tissue sarcomas. In: Journal of Surgical Oncology. 2005 ; Vol. 91, No. 3. pp. 153-158.
@article{8b9e87cae5954387ab12306288a5346c,
title = "Outcomes of re-excision after unplanned excisions of soft-tissue sarcomas",
abstract = "Background and Objectives: Unplanned excisions of soft-tissue sarcomas of the extremities occur commonly. Our goal was to evaluate the presence of residual disease, the treatment outcomes as they relate to local and distant recurrence and 5-year survival, and the limb functional outcomes in patients with unplanned sarcoma excision who were treated with re-excision and adjuvant therapy. Methods: Between 1993 and 1999, 42 patients presented to our institution after unplanned excision of soft-tissue sarcomas. Of those 42 patients, 38 without gross residual disease or metastatic lesions formed the basis of this review. All 38 patients underwent revision wide excision; most (31) also received adjuvant therapy (radiation and/or chemotherapy). Clinical data were obtained from analysis of patient records and radiographic studies. Univariate analysis was performed with logistical regression, and multivariate analysis was performed with Cox modeling. Results: The overall 5-year survival rate was 91.3{\%} and the disease-free 5-year survival rate was 82.2{\%}. Univariate analysis showed that stage-III disease (American Joint Committee on Cancer classification of soft-tissue sarcomas), lesions below the fascia, a histologic high-grade, and the development of organ metastasis were statistically significant factors for mortality. Stage-III disease also was significant for mortality on multivariate analysis. Only stage-III disease was significant for the development of local recurrence. Eighty-four percent of the patients had good to excellent functional outcomes. Conclusions: Re-excision with adjuvant therapy proved to be a safe and effective method for treating the disease and preserving limb function.",
keywords = "Predictive factors, Recurrence, Wide excision",
author = "Manoso, {Mark W.} and Deborah Frassica and Deune, {E Gene} and Frassica, {Frank J.}",
year = "2005",
month = "9",
day = "1",
doi = "10.1002/jso.20323",
language = "English (US)",
volume = "91",
pages = "153--158",
journal = "Journal of Surgical Oncology",
issn = "0022-4790",
publisher = "Wiley-Liss Inc.",
number = "3",

}

TY - JOUR

T1 - Outcomes of re-excision after unplanned excisions of soft-tissue sarcomas

AU - Manoso, Mark W.

AU - Frassica, Deborah

AU - Deune, E Gene

AU - Frassica, Frank J.

PY - 2005/9/1

Y1 - 2005/9/1

N2 - Background and Objectives: Unplanned excisions of soft-tissue sarcomas of the extremities occur commonly. Our goal was to evaluate the presence of residual disease, the treatment outcomes as they relate to local and distant recurrence and 5-year survival, and the limb functional outcomes in patients with unplanned sarcoma excision who were treated with re-excision and adjuvant therapy. Methods: Between 1993 and 1999, 42 patients presented to our institution after unplanned excision of soft-tissue sarcomas. Of those 42 patients, 38 without gross residual disease or metastatic lesions formed the basis of this review. All 38 patients underwent revision wide excision; most (31) also received adjuvant therapy (radiation and/or chemotherapy). Clinical data were obtained from analysis of patient records and radiographic studies. Univariate analysis was performed with logistical regression, and multivariate analysis was performed with Cox modeling. Results: The overall 5-year survival rate was 91.3% and the disease-free 5-year survival rate was 82.2%. Univariate analysis showed that stage-III disease (American Joint Committee on Cancer classification of soft-tissue sarcomas), lesions below the fascia, a histologic high-grade, and the development of organ metastasis were statistically significant factors for mortality. Stage-III disease also was significant for mortality on multivariate analysis. Only stage-III disease was significant for the development of local recurrence. Eighty-four percent of the patients had good to excellent functional outcomes. Conclusions: Re-excision with adjuvant therapy proved to be a safe and effective method for treating the disease and preserving limb function.

AB - Background and Objectives: Unplanned excisions of soft-tissue sarcomas of the extremities occur commonly. Our goal was to evaluate the presence of residual disease, the treatment outcomes as they relate to local and distant recurrence and 5-year survival, and the limb functional outcomes in patients with unplanned sarcoma excision who were treated with re-excision and adjuvant therapy. Methods: Between 1993 and 1999, 42 patients presented to our institution after unplanned excision of soft-tissue sarcomas. Of those 42 patients, 38 without gross residual disease or metastatic lesions formed the basis of this review. All 38 patients underwent revision wide excision; most (31) also received adjuvant therapy (radiation and/or chemotherapy). Clinical data were obtained from analysis of patient records and radiographic studies. Univariate analysis was performed with logistical regression, and multivariate analysis was performed with Cox modeling. Results: The overall 5-year survival rate was 91.3% and the disease-free 5-year survival rate was 82.2%. Univariate analysis showed that stage-III disease (American Joint Committee on Cancer classification of soft-tissue sarcomas), lesions below the fascia, a histologic high-grade, and the development of organ metastasis were statistically significant factors for mortality. Stage-III disease also was significant for mortality on multivariate analysis. Only stage-III disease was significant for the development of local recurrence. Eighty-four percent of the patients had good to excellent functional outcomes. Conclusions: Re-excision with adjuvant therapy proved to be a safe and effective method for treating the disease and preserving limb function.

KW - Predictive factors

KW - Recurrence

KW - Wide excision

UR - http://www.scopus.com/inward/record.url?scp=24344445263&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=24344445263&partnerID=8YFLogxK

U2 - 10.1002/jso.20323

DO - 10.1002/jso.20323

M3 - Article

VL - 91

SP - 153

EP - 158

JO - Journal of Surgical Oncology

JF - Journal of Surgical Oncology

SN - 0022-4790

IS - 3

ER -